Who
Kishan Mehta
Director
Company insider
Files Form 4 as: Director, Biohaven; Director, Benitec Biopharma; Director, Biohaven Pharmaceutical Holding Co; Director and Officer and 10% owner, Social Capital Suvretta Holdings Corp. I; Director and Officer and 10% owner, ProKidney; Director and Officer and 10% owner, Social Capital Suvretta Holdings Corp. II.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 15 Jun 2021
- Last trade
- 28 Apr 2026
- Last filed
- 30 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Apr 2026filed 30 Apr 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,693 at $0.00 | filing |
| 28 Apr 2026filed 30 Apr 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,693 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code G | —17,342 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code G | —17,342 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code G | —17,342 at $0.00 | filing |
| 17 Mar 2026filed 19 Mar 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code G | —17,342 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | BNTC Benitec Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 5 May 2025filed 7 May 2025 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,716 at $0.00 | filing |
| 9 Dec 2024filed 11 Dec 2024 | BNTC Benitec Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 30 Apr 2024filed 2 May 2024 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,592 at $0.00 | filing |
| 2 May 2023filed 4 May 2023 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,906 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —4,119 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —6,502 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —7,500 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —10,000 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,119 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,502 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.